Welcome to BC PharmaCare's public survey of drugs used for the primary prevention of osteoporosis. This survey includes oral bisphosphonates: etidronate (generics), alendronate 10 mg and 70 mg (generics), alendronate/cholecalciferol (generics), and risedronate (generics); IV bisphosphonate: zoledronic acid (Aclasta®, generics); selective estrogen receptor modulator: raloxifene (Evista® and generics), and biologic: denosumab (Prolia®).